Caplin Point Laboratories Ltd Nine Monthly Results

Gross Sales

1,435.02

1,240.88

1,077.45

930.17

782.58

Excise Duty

0

0

0

0

0

Net Sales

1,435.02

1,240.88

1,077.45

930.17

782.58

Other Operating Income

0

0

0

0

0

Other Income

70.69

49.86

44.58

27.24

14.08

Total Income

1,505.71

1,290.74

1,122.03

957.41

796.66

Total Expenditure

956.24

834.67

760.32

635.44

539.64

PBIDT

549.47

456.07

361.71

321.97

257.02

Interest

0.44

0.63

0.55

0.62

1.27

PBDT

549.03

455.44

361.16

321.35

255.75

Depreciation

48.92

37.04

33.86

35.45

27.11

Minority Interest Before NP

0

0

0

0

0

Tax

96.06

80.98

58.62

64.62

54.54

Deferred Tax

8.24

-2.77

-7.07

-6.34

-9.41

Reported Profit After Tax

395.81

340.19

275.75

227.62

183.51

Minority Interest After NP

2.07

4.69

1.59

6.84

7.62

Net Profit after Minority Interest

393.74

335.5

274.16

220.78

175.89

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

393.74

335.5

274.16

220.78

175.89

EPS (Unit Curr.)

51.82

44.19

36.17

29.18

23.25

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

15.2

15.19

15.18

15.15

15.13

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

38.29

36.75

33.57

34.61

32.84

PBDTM(%)

38.25

36.7

33.51

34.54

32.68

PATM(%)

27.58

27.41

25.59

24.47

23.44